Market News AIOpen the app

AGEN stock news · Agenus

Stories about Agenus (AGEN) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for AGEN

Follow Agenus (AGEN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for AGEN
Free on the App Store and Google Play, or on the web.
  1. Nov 6, 2026, 5:33 PM ET · Market

    Agenus said that more than 50% of patients with tough colorectal cancer lived longer after using its BOT+BAL treatment.

    Good for AGEN

    Agenus reported that more than 50% of patients in the study achieved long-term survival. This is favorable news for the company's drug combination.